Insight into the Mechanism of Inactivation of Ribonucleotide Reductase by Gemcitabine 5'-Diphosphate in the Presence or Absence of Reductant

Gemcitabine 5'-diphosphate (F[subscript 2]CDP) is a potent inhibitor of ribonucleotide reductases (RNRs), enzymes that convert nucleotides (NDPs) to deoxynucleotides and are essential for DNA replication and repair. The Escherichia coli RNR, an α2β2 complex, when incubated with 1 equiv of F[sub...

Full description

Bibliographic Details
Main Authors: Artin, Erin (Contributor), Wang, Jun (Contributor), Lohman, Gregory J. S. (Contributor), Yokoyama, Kenichi (Contributor), Yu, Guixue (Contributor), Bar, Galit (Contributor), Stubbe, JoAnne (Contributor), Griffin, Robert Guy (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Department of Chemistry (Contributor)
Format: Article
Language:English
Published: American Chemical Society (ACS), 2013-11-08T20:27:34Z.
Subjects:
Online Access:Get fulltext
LEADER 03260 am a22003853u 4500
001 82066
042 |a dc 
100 1 0 |a Artin, Erin  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Biology  |e contributor 
100 1 0 |a Massachusetts Institute of Technology. Department of Chemistry  |e contributor 
100 1 0 |a Artin, Erin  |e contributor 
100 1 0 |a Wang, Jun  |e contributor 
100 1 0 |a Lohman, Gregory J. S.  |e contributor 
100 1 0 |a Yokoyama, Kenichi  |e contributor 
100 1 0 |a Yu, Guixue  |e contributor 
100 1 0 |a Griffin, Robert Guy  |e contributor 
100 1 0 |a Bar, Galit  |e contributor 
100 1 0 |a Stubbe, JoAnne  |e contributor 
700 1 0 |a Wang, Jun  |e author 
700 1 0 |a Lohman, Gregory J. S.  |e author 
700 1 0 |a Yokoyama, Kenichi  |e author 
700 1 0 |a Yu, Guixue  |e author 
700 1 0 |a Bar, Galit  |e author 
700 1 0 |a Stubbe, JoAnne  |e author 
700 1 0 |a Griffin, Robert Guy  |e author 
245 0 0 |a Insight into the Mechanism of Inactivation of Ribonucleotide Reductase by Gemcitabine 5'-Diphosphate in the Presence or Absence of Reductant 
260 |b American Chemical Society (ACS),   |c 2013-11-08T20:27:34Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/82066 
520 |a Gemcitabine 5'-diphosphate (F[subscript 2]CDP) is a potent inhibitor of ribonucleotide reductases (RNRs), enzymes that convert nucleotides (NDPs) to deoxynucleotides and are essential for DNA replication and repair. The Escherichia coli RNR, an α2β2 complex, when incubated with 1 equiv of F[subscript 2]CDP catalyzes the release of two fluorides and cytosine concomitant with enzyme inactivation. In the presence of reductant (thioredoxin/thioredoxin reductase/NADPH or DTT), the enzyme inactivation results from its covalent labeling of α with the sugar of F[subscript 2]CDP (one label/α2β2). SDS-PAGE analysis of the inactivated RNR without boiling of the sample reveals that α migrates as an 87 and 110 kDa protein in a ratio of 0.6:0.4. When the reductant is omitted, RNR is inactivated by loss of the essential tyrosyl radical and formation of a new radical. Inactivation studies with C225S-α in the presence or absence of reductants, reveal it behaves like wt-RNR in the absence of reductant. Inactivated C225S-α migrates as an 87 kDa protein and is not covalently modified. C225 is one of the cysteines in RNR's active site that supplies reducing equivalents to make dNDPs. To identify the new radical formed, [1'-[superscript 2]H]-F[subscript 2]CDP was studied with wt- and C225S-RNR by 9 and 140 GHz EPR spectroscopy. These studies revealed that the new radical is a nucleotide derived with g values of g[subscript x] 2.00738, g[subscript y] 2.00592, and g[subscript z] 2.00230 and with altered hyperfine interactions (apparent triplet collapsed to a doublet) relative to [1'-[superscript 1]H]-F[subscript 2]CDP. The EPR features are very similar to those we recently reported for the nucleotide radical generated with CDP and E441Q-RNR. 
520 |a National Institutes of Health (U.S.) (Grant GM29595) 
520 |a National Institutes of Health (U.S.) (Grant EB-002804) 
520 |a National Institutes of Health (U.S.) (Grant EB-002026) 
546 |a en_US 
655 7 |a Article 
773 |t Biochemistry